Dissolution and absorption of the antineoplastic agent ellipticine

Area of Science:

• Pharmacology and Pharmaceutics
• Medicinal Chemistry
• Oncology

Background:

• Ellipticine is a potent alkaloid with demonstrated activity in experimental tumor models.
• Poor aqueous solubility limits the therapeutic efficacy and oral bioavailability of ellipticine.
• Developing formulations to enhance ellipticine solubility is crucial for its clinical application.

Purpose of the Study:

• To investigate the effect of polyvinylpyrrolidone (PVP) on the solubility and dissolution of ellipticine.
• To compare the physiological disposition and antitumor activity of ellipticine formulated with PVP versus its hydrochloride salt and suspension.
• To evaluate the potential of PVP as a solubilizing agent for improving ellipticine's oral absorption and efficacy.

Main Methods:

• Solubility studies of ellipticine with varying molecular weights of polyvinylpyrrolidone (10,000–160,000).
• Dissolution testing of ellipticine-PVP tablets in simulated gastric juice.
• Pharmacokinetic analysis of ellipticine tissue levels in fasted mice after oral administration of ellipticine-PVP, ellipticine hydrochloride, and ellipticine suspension.
• Antitumor efficacy evaluation against L-1210 leukemia via intraperitoneal and oral routes.

Main Results:

• Polyvinylpyrrolidone significantly increased ellipticine solubility, with optimal results using PVP mol. wt 10,000 (approx. 13 mg/ml).
• Ellipticine-PVP tablets exhibited superior dissolution in simulated gastric juice compared to ellipticine hydrochloride.
• Oral administration of ellipticine-PVP resulted in approximately threefold higher ellipticine tissue levels compared to the suspension.
• The optimal dose for ellipticine-PVP and ellipticine hydrochloride was lower than the suspension, indicating enhanced absorption and improved antitumor activity.

Conclusions:

• Polyvinylpyrrolidone, particularly with a molecular weight of 10,000, effectively enhances the solubility and dissolution of ellipticine.
• Formulation with PVP improves the oral absorption and bioavailability of ellipticine, leading to increased tissue drug levels.
• Ellipticine-PVP demonstrates promising potential for improved antitumor efficacy due to enhanced absorption, warranting further investigation.